NCT03015896 2025-09-29Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaOhio State University Comprehensive Cancer CenterPhase 1/2 Active not recruiting36 enrolled